Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | AJCC TNM Post Therapy Path (yp) T Suffix (AJCC8TNMPostTxTSfx) | 33163 | Yes |
AJCC | AJCC TNM Post Therapy Path (yp) T Suffix | Yes |
Field length: 4
This field will be used for cases 01/01/2018 and forward.
Description
Detailed site-specific codes for the postneoadjuvant therapy T category suffix as defined by AJCC 8th edition.
Rationale
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Codes (as published in the AJCC 8th edition Cancer Staging Manual)
| Code | Description |
|---|---|
| (m) | Multiple synchronous tumors OR For thyroid differentiated and anaplastic only, Multifocal tumor |
| (s) | For thyroid differentiated and anaplastic only, Solitary tumor |
| Blank | No information available; not recorded |
Note: Refer to the current AJCC 8th edition Cancer Staging Manual for staging rules.
Overview
Content Tools
Activity